Renal Function Dynamics Following Co-Administration of Sacubitril/Valsartan and Empagliflozin in Patients with Heart Failure and Type 2 Diabetes - Concepedia

Concepedia

Publication | Open Access

Renal Function Dynamics Following Co-Administration of Sacubitril/Valsartan and Empagliflozin in Patients with Heart Failure and Type 2 Diabetes

DOI Full Paper Access

14

Citations

14

References

2020

Year

Rafael de la Espriella, Antoni Bayés‐Genís, Herminio Morillas, Rafael Bravo, Verónica Vidal, Eduardo Núñez, Enrique Santas, Gema Miñana, Juan Sanchís, Lorenzo Fácila,

ESC Heart Failure

Abstract

The co-administration of sacubitril/valsartan and empagliflozin in patients with HFrEF and concomitant T2D appears to be safe in terms of renal function.

References

	Year	Citations

Page 1